Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BAX | Baxter International Inc.

IndexS&P 500 P/E- EPS (ttm)-5.86 Insider Own0.27% Shs Outstand506.00M Perf Week-3.53%
Market Cap19.13B Forward P/E12.28 EPS next Y3.07 Insider Trans0.00% Shs Float505.01M Perf Month-8.96%
Income-2952.00M PEG- EPS next Q0.67 Inst Own89.50% Short Float / Ratio1.42% / 1.61 Perf Quarter-16.30%
Sales14.88B P/S1.29 EPS this Y-291.00% Inst Trans0.70% Short Interest7.17M Perf Half Y-1.10%
Book/sh11.01 P/B3.42 EPS next Y19.32% ROA-10.20% Target Price50.42 Perf Year-32.04%
Cash/sh3.39 P/C11.11 EPS next 5Y4.63% ROE-50.00% 52W Range37.35 - 58.23 Perf YTD-26.03%
Dividend1.16 P/FCF22.16 EPS past 5Y-33.50% ROI-9.60% 52W High-35.26% Beta0.62
Dividend %3.08% Quick Ratio0.90 Sales past 5Y7.40% Gross Margin35.60% 52W Low0.95% ATR0.84
Employees60000 Current Ratio1.40 Sales Q/Q3.10% Oper. Margin-16.90% RSI (14)27.95 Volatility1.70% 2.19%
OptionableYes Debt/Eq2.96 EPS Q/Q-207.60% Profit Margin-19.20% Rel Volume0.99 Prev Close38.11
ShortableYes LT Debt/Eq2.57 EarningsJul 27 BMO Payout- Avg Volume4.45M Price37.70
Recom2.60 SMA20-5.16% SMA50-11.91% SMA200-13.92% Volume4,388,533 Change-1.08%
Date Action Analyst Rating Change Price Target Change
May-30-23Resumed Morgan Stanley Equal-Weight $45
Mar-29-23Initiated UBS Neutral $43
Jan-06-23Downgrade Morgan Stanley Overweight → Equal-Weight $55
Jan-05-23Downgrade Raymond James Outperform → Mkt Perform
Jan-03-23Downgrade BofA Securities Buy → Neutral $66 → $55
Dec-19-22Downgrade JP Morgan Overweight → Neutral $68 → $55
Dec-15-22Downgrade Deutsche Bank Buy → Hold $69 → $51
Dec-12-22Downgrade Citigroup Buy → Neutral $64 → $58
Oct-18-22Initiated Barclays Overweight $64
Oct-12-22Initiated Jefferies Hold $62
Sep-21-23 06:55PM
Sep-19-23 04:15PM
Sep-12-23 08:43AM
Sep-07-23 01:44PM
12:32PM Loading…
Aug-31-23 12:32PM
Aug-29-23 04:15PM
Aug-24-23 08:30AM
Aug-22-23 04:15PM
Aug-21-23 05:00PM
Aug-14-23 07:02PM
Aug-11-23 10:28AM
Aug-05-23 08:10AM
Jul-31-23 10:24AM
09:59AM Loading…
Jul-27-23 11:32AM
Jul-25-23 08:15AM
Jul-24-23 08:00AM
Jul-22-23 08:06AM
Jul-21-23 09:57AM
Jul-20-23 10:02AM
Jul-18-23 04:15PM
Jul-12-23 02:31AM
10:37AM Loading…
Jul-08-23 10:37AM
Jul-07-23 12:52PM
Jun-30-23 10:45AM
Jun-29-23 04:15PM
Jun-27-23 09:00AM
Jun-26-23 08:30AM
Jun-21-23 10:16AM
Jun-13-23 04:30PM
Jun-12-23 03:23PM
May-27-23 08:24AM
May-24-23 04:15PM
May-23-23 08:04AM
May-19-23 06:23AM
May-09-23 09:00AM
May-08-23 10:39AM
May-05-23 09:10AM
May-02-23 11:40AM
May-01-23 04:45PM
Apr-28-23 02:11PM
Apr-27-23 01:15PM
Apr-26-23 10:52AM
Apr-25-23 09:40AM
Apr-21-23 12:11PM
Apr-20-23 07:12AM
Apr-19-23 04:15PM
Apr-10-23 11:13AM
Apr-06-23 04:15PM
Apr-05-23 06:53PM
Apr-04-23 09:00AM
Apr-03-23 09:00AM
Mar-29-23 09:00AM
Mar-20-23 05:43PM
Mar-15-23 11:27PM
Mar-14-23 12:42PM
Mar-10-23 06:57PM
Mar-05-23 07:38AM
Mar-04-23 07:35AM
Feb-26-23 05:30AM
Feb-14-23 04:30PM
Feb-11-23 07:11AM
Feb-10-23 05:33PM
Feb-09-23 01:21PM
Feb-06-23 10:00AM
Feb-02-23 10:00AM
Feb-01-23 08:00AM
Jan-31-23 04:48PM
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules; and a collaborative research agreement with Miromatrix Medical Inc. to develop treatments for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is based in Deerfield, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STROUCKEN ALBERT P LDirectorMar 20Option Exercise36.933,930145,13540,765Mar 22 04:05 PM
STROUCKEN ALBERT P LDirectorMar 20Sale37.523,930147,45436,835Mar 22 04:05 PM
Kunzler JacquelineSVP, Chief Quality OfficerFeb 21Option Exercise37.824,163157,44520,538Feb 23 04:03 PM
Kunzler JacquelineSVP, Chief Quality OfficerFeb 21Sale40.503,813154,42616,725Feb 23 04:03 PM
Mason Jeanne KSVP, Human ResourcesJan 17Option Exercise37.8259,4772,249,420185,708Jan 19 04:36 PM
Mason Jeanne KSVP, Human ResourcesJan 17Sale44.7059,4772,658,622126,231Jan 19 04:36 PM